We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Kodak
KODK
$788M
| $190K | ﹤0.01% |
20,829
+3,300
| +19% | +$33K |
|
|
HALL
852
DELISTED
Hallmark Financial Services, Inc.
HALL
| $190K | ﹤0.01% |
1,687
| – | – |
|
853
Rocky Brands
RCKY
$302M
| $188K | ﹤0.01% |
+13,973
| New | +$187K |
|
854
Acco Brands
ACCO
$362M
| $185K | ﹤0.01% |
+15,900
| New | +$198K |
|
|
RNWK
855
DELISTED
RealNetworks Inc
RNWK
| $185K | ﹤0.01% |
42,653
+20,450
| +92% | +$89.4K |
|
856
KVH Industries
KVHI
$176M
| $184K | ﹤0.01% |
19,375
-19,735
| -50% | -$176K |
|
|
RATE
857
DELISTED
Bankrate Inc
RATE
| $181K | ﹤0.01% |
14,100
-1,000
| -7% | -$10.7K |
|
|
IO
858
DELISTED
ION Geophysical Corporation
IO
| $178K | ﹤0.01% |
40,988
+18,629
| +83% | +$81.5K |
|
|
CY
859
DELISTED
Cypress Semiconductor
CY
| $176K | ﹤0.01% |
+12,900
| New | +$176K |
|
|
KDNY
860
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $173K | ﹤0.01% |
+3,040
| New | +$153K |
|
|
DCOY
861
Decoy Therapeutics
DCOY
$2.63M
| – | – |
0
| – | – |
|
|
TBCH
862
Turtle Beach Corp
TBCH
$241M
| $171K | ﹤0.01% |
+61,226
| New | +$198K |
|
863
IDT Corp
IDT
$1.56B
| $165K | ﹤0.01% |
13,585
-5,555
| -29% | -$72K |
|
864
Diamondrock Hospitality Co
DRH
$2.59B
| $163K | ﹤0.01% |
14,900
+4,700
| +46% | +$52.5K |
|
865
Fate Therapeutics
FATE
$294M
| $162K | ﹤0.01% |
50,004
-10,700
| -18% | -$41K |
|
|
EXA
866
DELISTED
EXA Corporation
EXA
| $162K | ﹤0.01% |
+11,723
| New | +$158K |
|
|
VYNT
867
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $159K | ﹤0.01% |
268
| – | – |
|
868
Clarus
CLAR
$125M
| $158K | ﹤0.01% |
23,930
-20,266
| -46% | -$119K |
|
869
Nabors Industries
NBR
$1.25B
| $158K | ﹤0.01% |
388
-1,538
| -80% | -$774K |
|
|
PTX
870
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $158K | ﹤0.01% |
+39,300
| New | +$171K |
|
|
SNMX
871
DELISTED
Senomyx, Inc.
SNMX
| $157K | ﹤0.01% |
188,556
+38,094
| +25% | +$33.8K |
|
872
Graphic Packaging
GPK
$3.25B
| $150K | ﹤0.01% |
10,900
-1,100
| -9% | -$14.8K |
|
|
ICAD
873
DELISTED
iCAD Inc
ICAD
| $145K | ﹤0.01% |
34,512
+23,807
| +222% | +$115K |
|
|
MNI
874
DELISTED
The McClatchy Company Class A Common Stock
MNI
| $145K | ﹤0.01% |
15,489
+239
| +2% | +$2.4K |
|
|
CTIC
875
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $145K | ﹤0.01% |
43,720
+11,483
| +36% | +$44.7K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.